- Home
- CLDX vs ERO Comparison
CLDX vs ERO Comparison
Compare CLDX & ERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLDX | ERO |
|---|---|---|
| Founded | N/A | 2016 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.7B |
| IPO Year | 1995 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CLDX | ERO |
|---|---|---|
| Price | $35.57 | $24.11 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 2 |
| Target Price | ★ $46.60 | $36.50 |
| AVG Volume (30 Days) | ★ 1.3M | 1.0M |
| Earning Date | 05-04-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,743,000.00 | N/A |
| Revenue This Year | $111.39 | $51.94 |
| Revenue Next Year | $235.85 | $2.43 |
| P/E Ratio | ★ N/A | $22.61 |
| Revenue Growth | ★ 87.78 | N/A |
| 52 Week Low | $19.72 | $12.79 |
| 52 Week High | $40.30 | $39.80 |
Technical Indicators
Market Signals| Indicator | CLDX | ERO |
|---|---|---|
| Relative Strength Index (RSI) | 49.03 | 41.10 |
| Support Level | $28.51 | $22.98 |
| Resistance Level | $40.30 | $24.48 |
| Average True Range (ATR) | 1.76 | 1.23 |
| MACD | -0.38 | -0.10 |
| Stochastic Oscillator | 20.07 | 31.01 |
Price Performance
Historical ComparisonAbout CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About ERO Ero Copper Corp.
Ero Copper Corp is a high-margin, high-growth copper producer with operations in Brazil. Its primary asset is its 99.6% ownership interest in Mineracao Caraiba S.A., held indirectly through its wholly-owned subsidiary. The company also owns a 97.6% ownership interest in NX Gold S.A. indirectly through its wholly-owned subsidiary. Its reporting segments include its three operating mines in Brazil, the Caraiba Operations, the Tucuma Operation, and the Xavantina Operations, and its corporate head office in Canada.